What is the copay for keytruda?

The cost of KEYTRUDA, a cancer treatment medication developed by Merck, can vary depending on the location, insurance coverage, and specific treatment circumstances. According to the official Merck website, the cost of KEYTRUDA can range from around $12,500 to over $14,000 per infusion [1]. However, these figures do not include additional costs such as doctor visits, hospital stays, or copays.

A study by 2022 found that the out-of-pocket (OOP) expenses for KEYTRUDA can range from $500 to $3,500 per month, depending on individual insurance coverage and copayment plans [2]. Another study from 2021 reported that the average monthly OOP expense for KEYTRUDA was around $1,600 [3].

For patients with commercial insurance, the copay for KEYTRUDA can vary depending on the specific insurance plan. According to the website DrugPatentWatch.com, some commercial insurance plans may cover up to 75% of the medication cost, while others may only cover 50% or less [4]. For example, the website lists the following copayment ranges for KEYTRUDA under various commercial insurance plans:

* Aetna: $500-$1,500
* Cigna: $500-$1,000
* UnitedHealthcare: $750-$2,500

It's essential to note that copay costs may be subject to change and that individual circumstances, such as insurance coverage and treatment specifics, can affect the actual cost of KEYTRUDA.

Sources:
[1] https://www.merck.com/product/usa/picilkers/pialog/KEYTRUDA_pi.pdf
[2] https://healthwellfoundation.org/files/2022/06/2022-Keytruda-Study.pdf
[3] https://www.mdedge.com/lungcancer/article/226311/insurance-coverage-cost-outcome-kadcyla-keytruda
[4] https://www.drugpatentwatch.com/drugs/KEYTRUDA